Amplicare announced today that its Board of Directors has appointed Matt Johnson, Pharm.D., as Chief Executive Officer effective August 1, 2018. Flaviu Simihaian, Amplicare’s co-founder, will assume the role as Chairman of the Board of Directors and step down from his role as Chief Executive Officer to pursue other investment opportunities in healthcare. Jess Eberdt joins as a Director on the Board.
Johnson has served as Amplicare’s Chief Operating Officer and as a Director on the Board since starting the Company in 2012. Simihaian remains a major shareholder of the company and will provide a seamless transition while remaining involved as needed. Eberdt was co-founder and Chief Executive Officer of Parata System; Chairman of Parelio Systems prior to its acquisition by Arthrexs and currently serves as Managing Director of TempusDurham.
“It has been an honor to serve as the CEO of Amplicare since founding the company together with Matt and I am proud of how our team has grown and accomplished together in the past 6 years,” said Simihaian. “We grew our workflow automation platform for pharmacies beyond iMedicare so that efficiencies and improved patient care can be implemented year-round for more patients beyond those on Medicare.”
“The Board and I have no doubt that Matt is the right person to build on this momentum,” Simihaian continued. “As a Pharm.D., Matt has walked in the shoes of our clients and possesses domain knowledge that will help us continue to build on our platform to address the needs of pharmacists and healthcare providers. Our clients will greatly benefit from having him as our next CEO. Having Jess on our Board with his experience in start-up and high-growth healthcare companies, helps us with insights on scaling the firm to every pharmacy in the country.”
“Matt is a natural leader for Amplicare’s future, and he has the unanimous support of the Board of Directors,” said Eberdt. “I am thrilled to be a part of Amplicare’s board. The board has a strong focus on succession planning to ensure the best leader for our employees, clients, partners and shareholders. With Flaviu serving as Chairman and Matt taking the role of CEO, the board is confident that Amplicare has the right leadership in place to drive its success for the next phase of the company.”
As Amplicare’s Chief Operating Officer and co-founder, Johnson oversaw the product development of its first product, iMedicare, and was also instrumental in shaping the development of the expanded Amplicare platform, especially in the clinical arena.
“I am honored to assume this new role and am excited for the future of the company,” said Johnson. “We continue to build an amazingly talented team at Amplicare that is truly passionate about delivering solutions that help pharmacists become healthcare superheroes in their communities. And I look forward to continuing the conversation with fellow healthcare providers so that we can service them better and in more ways that make a meaningful impact in their practices.”
Amplicare is the leading decision-automation platform that intelligently identifies relevant opportunities for healthcare providers to proactively improve patient care. The benefits of the platform are to help providers more efficiently impact their patient community in more ways, while providing better healthcare options for their patients. With over 5,000 pharmacy subscribers, Amplicare delivers an unrivaled platform that increases patient retention, improves performance measures, grows and diversifies revenue streams, and enables providers to communicate with their patients more easily than ever before. For more information, visit www.amplicare.com.